- Home
- DFDV vs HUMA Comparison
DFDV vs HUMA Comparison
Compare DFDV & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFDV
- HUMA
- Stock Information
- Founded
- DFDV 2018
- HUMA 2004
- Country
- DFDV United States
- HUMA United States
- Employees
- DFDV N/A
- HUMA N/A
- Industry
- DFDV Finance: Consumer Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- DFDV Finance
- HUMA Health Care
- Exchange
- DFDV Nasdaq
- HUMA Nasdaq
- Market Cap
- DFDV 330.2M
- HUMA 250.2M
- IPO Year
- DFDV N/A
- HUMA N/A
- Fundamental
- Price
- DFDV $16.02
- HUMA $1.51
- Analyst Decision
- DFDV Buy
- HUMA Strong Buy
- Analyst Count
- DFDV 1
- HUMA 8
- Target Price
- DFDV $45.00
- HUMA $10.88
- AVG Volume (30 Days)
- DFDV 3.5M
- HUMA 5.9M
- Earning Date
- DFDV 08-12-2025
- HUMA 08-11-2025
- Dividend Yield
- DFDV N/A
- HUMA N/A
- EPS Growth
- DFDV N/A
- HUMA N/A
- EPS
- DFDV 1.17
- HUMA N/A
- Revenue
- DFDV $3,520,660.00
- HUMA $818,000.00
- Revenue This Year
- DFDV $70.03
- HUMA N/A
- Revenue Next Year
- DFDV $142.86
- HUMA $949.92
- P/E Ratio
- DFDV $13.67
- HUMA N/A
- Revenue Growth
- DFDV 97.13
- HUMA N/A
- 52 Week Low
- DFDV $0.49
- HUMA $1.15
- 52 Week High
- DFDV $53.88
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- DFDV 46.25
- HUMA 36.87
- Support Level
- DFDV $15.23
- HUMA $1.43
- Resistance Level
- DFDV $20.30
- HUMA $1.67
- Average True Range (ATR)
- DFDV 2.30
- HUMA 0.15
- MACD
- DFDV 0.08
- HUMA -0.01
- Stochastic Oscillator
- DFDV 19.72
- HUMA 23.32
About DFDV DeFi Development Corp. Common Stock
DeFi Development Corp is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions as well as value-add services to multifamily and commercial property professionals.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.